We have come far in the last year. SPPI running their own trail, trail for her2, first line therapy trail. Combo therapy. Rolontis closer to hitting the streets. Lung cancer, breast cancer, other areas of cancer. 1 year ago we were wondering what types of cancer had the exon 20 mutation. Holy cow of course the stock will shoot up, this is a world stage. I have the time and a fairly pure mind to read all of UKs posts. It all makes sense. How many Bio companys that are similar to spectrum get bought out. They have MDACC involved, Hamni involved. It will be complicated. Maybe we don't need that info. But keep an open mind and be nice.